| Inhaled Long-acting Bronchodilators With or Without Inhaled Glucocorticosteroids for Preventing Hospitalizations and Death in Elderly Patients With Chronic Obstructive Pulmonary Disease (NCT03662711) | Università degli Studi di Ferrara | 2018-11-11 |
| Abnormal Pain Processing in COPD Patients (NCT04319523) | Universidad de Granada | 2018-11-01 |
| Training of Inhalation Technique in Hospitalized Chronic Obstructive Pulmonary Disease (COPD) Patients - a Pilot Study (NCT03691324) | Oslo University College | 2018-09-26 |
| The Study for Evaluating Factors Relating to Daily Step Counts and Physical Activity in Japanese Patients With COPD. (NCT03642613) | AstraZeneca | 2018-09-14 |
| A Study to Assess the Pulmonary Distribution of Budesonide, Glycopyrronium and Formoterol Fumarate (NCT03740373) | AstraZeneca | 2018-09-04 |
| A Study on the Control of Chronic Obstructive Pulmonary Disease (COPD) in Patients Taking the Combination of Tiotropium and Olodaterol Using the Respimat® Inhaler (NCT03663569) | Boehringer Ingelheim | 2018-08-15 |
| The OPTI Study in Spain Looks at the History Flare-ups in Patients With Chronic Obstructive Pulmonary Disease (COPD) Treated With Inhaled Steroids. (NCT03611777) | Boehringer Ingelheim | 2018-08-14 |
| Sensor and Electronic Health Records (EHR) Integration Pilot Study (NCT03357341) | GlaxoSmithKline | 2018-07-23 |
| Study of the Involvement of IL-17 / IL-22 Pathway in Bacterial Exacerbations of COPD (NCT02655302) | University Hospital, Lille | 2018-07-04 |
| Efficacy of Acupuncture in Exercise Tolerance in Patients With COPD (NCT03767140) | Instituto de Ciências Biomédicas Abel Salazar | 2018-06-27 |
| High-Flow Nasal Oxygen Therapy for Exacerbation of Chronic Pulmonary Obstructive Disease. (NCT03488628) | Centre Hospitalier Régional d'Orléans | 2018-06-27 |
| A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD) (NCT03478683) | GlaxoSmithKline | 2018-06-25 |
| A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC /VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD) (NCT03478696) | GlaxoSmithKline | 2018-06-25 |
| Differences of Small Airways Function Between Chronic Obstructive Pulmonary Disease(COPD) and Asthma-copd Overlap(ACO) (NCT03563001) | Zhujiang Hospital | 2018-06-20 |
| A Prospective Cohort Study of Asthma and COPD Overlap in Japanese COPD Patients Using the Diagnostic Criteria of The Japanese Respiratory Society (NCT03577795) | AstraZeneca | 2018-06-19 |
| Change of Lung Function After Exercise in Patients With Chronic Obstructive Pulmonary Disease (NCT03551197) | Zhujiang Hospital | 2018-06-13 |
| Chronic Obstructive Pulmonary Disease (COPD) Dual Therapy Burden of Illness (NCT03543176) | GlaxoSmithKline | 2018-05-31 |
| Does Pulmonary Rehabilitation Improve Breathing of COPD Patients (NCT01815970) | University of British Columbia | 2018-05-01 |
| Use of Diagnostic Measures in Chronic Obstructive Pulmonary Disease (COPD) in Routine Practice and Their Impact on Treatment Decisions (NCT03465332) | GlaxoSmithKline | 2018-04-19 |
| INTREPID: Investigation of TRELEGY Effectiveness: Usual Practice Design (NCT03467425) | GlaxoSmithKline | 2018-04-11 |
| Calprotectin I Serum as a Diagnostic Marker (NCT03474484) | St. Olavs Hospital | 2018-04-03 |
| Acupoint Transcutaneous Electrical Nerve Stimulation in Hospitalized COPD Patients With Severe Dyspnoea (NCT02998957) | Fundació Sant Joan de Déu | 2018-04-01 |
| A Comparative Study Between Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Single Inhaler Triple Therapy Versus Tiotropium Monotherapy in Subjects With Chronic Obstructive Pulmonary Disease (COPD) (NCT03474081) | GlaxoSmithKline | 2018-03-29 |
| Study of Automated Care Pathway for Patients With Chronic Obstructive Pulmonary Disease (COPD) (NCT03028805) | University of California, San Francisco | 2018-03-26 |
| Greek NIS Spiolto ELLACTO (NCT03419962) | Boehringer Ingelheim | 2018-03-19 |
| GSK1325756 Relative Bioavailability Study in Healthy Elderly Subjects (NCT03457727) | GlaxoSmithKline | 2018-03-07 |
| Feasibility and Effect of a Follow up Tele-rehabilitation Program for Chronic Obstructive Lung Disease vs. Standard Follow up (NCT03443817) | University of Aarhus | 2018-03-01 |
| Effects of Traditional Chinese Medicine on AECOPD Patients (NCT03428412) | Henan University of Traditional Chinese Medicine | 2018-03-01 |
| Bayis Ilh Tus - A Strong Breath: Prevalence and Contributors to COPD in First Nations Communities in British Columbia (NCT04105088) | University of British Columbia | 2018-02-13 |
| Peripheral Nerve Blocks for Above-the-knee Amputations (NCT03404180) | University of Florida | 2018-02-09 |
| Cardiovascular Events in Chronic Obstructive Pulmonary Disease Patients Initiating Olodaterol or Other Long-acting beta2 Agonists (NCT03405363) | Boehringer Ingelheim | 2018-01-31 |
| Oscillating Positive Expiratory Pressure Devices and Acute Exacerbation of Chronic Obstructive Pulmonary Disease (NCT03299231) | Ain Shams University | 2018-01-22 |
| A Study to Evaluate the Effect of Itraconazole on the Pharmacokinetics (PK) of Nemiralisib (NCT03398421) | GlaxoSmithKline | 2018-01-17 |
| Effects of Liraglutide in Chronic Obstructive Pulmonary Disease (NCT03466021) | Claus Bogh Juhl | 2018-01-01 |
| Сohort Study to Evaluate Exacerbations, Respiratory Symptoms, Physical Exercise Intolerance and Lung Functions Among Participants Who Use IQOS With Heatsticks Compared to Smokers of Conventional Cigarettes (NCT03383601) | Kazakhstan Academy of Preventive Medicine | 2017-12-16 |
| Burden of Disease Among Subjects With Eosinophilic Chronic Obstructive Pulmonary Disease (COPD) (NCT03436511) | GlaxoSmithKline | 2017-12-05 |
| Dose Finding Study of Nemiralisib (GSK2269557) in Subjects With an Acute Moderate or Severe Exacerbation of Chronic Obstructive Pulmonary Disease (COPD) (NCT03345407) | GlaxoSmithKline | 2017-11-28 |
| Randomized Study Evaluating the Effect of Danirixin on Neutrophil Extracellular Traps (NETs) in Chronic Obstructive Pulmonary Disease (COPD) (NCT03250689) | GlaxoSmithKline | 2017-11-15 |
| Absorption & Elimination of Radiolabelled GSK2269557 (NCT03315559) | GlaxoSmithKline | 2017-11-14 |
| A Pilot Study of Danirixin for Disease Progression in Chronic Obstructive Pulmonary Disease (COPD) (NCT03170232) | GlaxoSmithKline | 2017-10-16 |
| Evaluating the Clinical Effectiveness of 3D Printing for a Patient-specific Silicone Stent Airway Implant (NCT03111888) | The Cleveland Clinic | 2017-10-01 |
| The Development, Implementation and Evaluation of Clinical Pathways for Chronic Obstructive Pulmonary Disease (COPD) in Saskatchewan (NCT03075709) | University of Saskatchewan | 2017-09-30 |
| Assessment In a Real World Setting of the Effect of Inhaled Steroid-based Triple Therapy Versus the Combination of Tiotropium and Olodaterol on Reducing Chronic Obstructive Pulmonary Disease (COPD) Exacerbations [AIRWISE] (NCT03265145) | Boehringer Ingelheim | 2017-09-20 |
| Comparative Study of ELLIPTA Dry Powder Inhaler (DPI) Versus DISKUS DPI Used With HandiHaler DPI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) (NCT03227445) | GlaxoSmithKline | 2017-09-20 |
| Sleep and Daytime Use of Humidified Nasal High-flow Oxygen in COPD Outpatients (NCT03221387) | Temple University | 2017-09-10 |
| Dynamic Hyperinflation In Mechanically Ventilated Chronic Obstructive Pulmonary Disease Patients (NCT03230617) | Assiut University | 2017-09-01 |
| RELVAR® 100 ELLIPTA® Special Drug Use Investigation (COPD, Long-term) (NCT03219255) | GlaxoSmithKline | 2017-08-30 |
| The ENERGITO® 2 Study Compares 2 Inhaled Medicines for Chronic Obstructive Pulmonary Disease (COPD). One Medicine is a Combination of Tiotropium and Olodaterol (Stiolto®) Taken Using the Respimat® Inhaler and the Other Medicine is a Combination of Fluticasone and Salmeterol Taken Using the Diskus (NCT03240575) | Boehringer Ingelheim | 2017-08-14 |
| Modeling Bronchial Epithelium Modifications Associated With COPD Using iPS (NCT03181204) | University Hospital, Montpellier | 2017-08-07 |
| Study of Safety and Drug Levels of CCI15106 Inhalation Powder in Healthy Adults and Adults With Moderate Chronic Obstructive Pulmonary Disease. Study of CCI15106 Levels in People Standing Near the Person Inhaling the Drug (NCT03235726) | GlaxoSmithKline | 2017-07-13 |
| A 24-week Study to Compare Umeclidinium/Vilanterol (UMEC/VI), UMEC and Salmeterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD) (NCT03034915) | GlaxoSmithKline | 2017-06-16 |
| Safety, Tolerability and Pharmacokinetics (PK) Study of GSK2269557 in Healthy Subjects (NCT03189589) | GlaxoSmithKline | 2017-06-15 |
| Comparative Study of Error Rates Between ELLIPTA® Dry Powder Inhaler (DPI) and Other DPIs (NCT03114969) | GlaxoSmithKline | 2017-06-08 |
| Patient Characteristics and Treatment Modalities in COPD Patients in China (NCT03161587) | GlaxoSmithKline | 2017-05-31 |
| Changes in Health and Functional Status in Patients With Chronic Obstructive Pulmonary Disease During Therapy With Spiolto® Respimat® (AERIAL®) (NCT03165045) | Boehringer Ingelheim | 2017-05-26 |
| INtervention Study In overweiGHT Patients With COPD (NCT02634268) | Seattle Institute for Biomedical and Clinical Research | 2017-05-12 |
| Study of Danirixin in Japanese Healthy Elderly Male Subjects (NCT03136380) | GlaxoSmithKline | 2017-05-10 |
| Effect of Acupuncture on Patients With Chronic Obstructive Pulmonary Disease (NCT03169504) | Henan University of Traditional Chinese Medicine | 2017-05-01 |
| OTIVACTO Spain Non Interventional Study (NCT02927795) | Boehringer Ingelheim | 2017-04-26 |
| Danirixin Dose Ranging Study in Participants With Chronic Obstructive Pulmonary Disease (COPD) (NCT03034967) | GlaxoSmithKline | 2017-04-25 |
| NRS 2002 as a Predictor of Prognosis in COPD With Respiratory Failure (NCT02942797) | West China Hospital | 2017-04-01 |
| Aerobic Interval Training in Patients With Chronic Obstructive Pulmonary Disease (COPD) and Hypoxemia (NCT03092622) | Norwegian University of Science and Technology | 2017-04-01 |
| A Comparison of Three Nutritional Assessment Methods Predicting Prognosis in COPD With Respiratory Failure (NCT02942784) | West China Hospital | 2017-04-01 |
| Cardiovascular Function in COPD Patients (NCT03055988) | Boehringer Ingelheim | 2017-03-29 |
| The Effect of Respiratory Training on Exercise Tolerance in COPD (NCT04201522) | Laval University | 2017-03-14 |
| A Cross-sectional Study on COPD Prevalence (NCT03028207) | GlaxoSmithKline | 2017-03-09 |
| Aclidinium Bromide Post-Authorisation Safety Study to Evaluate the Risk of Cardiovascular Endpoints (NCT03290287) | AstraZeneca | 2017-03-01 |
| Ventilation and Pulmonary Endothelium Toxicities of E-cigarettes: A Randomized Crossover Pilot Study (NCT02783768) | Columbia University | 2017-03-01 |
| COPD Discharge Bundle Delivered Alone or Enhanced Through a Care Coordinator (NCT03358771) | University of Alberta | 2017-03-01 |
| Bioavailability of Tiotropium + Olodaterol Fixed-dose Combination (5 μg/ 5 μg) in Chinese COPD Patients (NCT02969317) | Boehringer Ingelheim | 2017-02-24 |
| Drug Utilization Study for Olodaterol (NCT03030638) | Boehringer Ingelheim | 2017-02-08 |
| Influence of a Multi-parametric Optimization Strategy for General Anesthesia on Postoperative Morbidity and Mortality (NCT02668250) | Centre Hospitalier Universitaire de Saint Etienne | 2017-02-03 |
| Effects of Upper-limb Training Addition to a Conventional ET Program on PA Level and ADL Performance. (NCT03127878) | Universidade Estadual de Londrina | 2017-01-12 |
| Home COPD and Open Ventilation Evaluation (HOPE) Study (NCT03691181) | Landon Pediatric Foundation | 2017-01-01 |
| The Gut-lung Axis in Chronic Obstructive Pulmonary Disease (NCT03236480) | Peking University People's Hospital | 2017-01-01 |
| A Clinical Study Assessing Critical Errors, Training/Teaching Time, and Preference Attributes of the ELLIPTA® Dry Powder Inhaler, in Comparison to Combinations of Dry Powder Inhalers Used to Provide Triple Therapy, in Patients With Chronic Obstructive Pulmonary Disease (NCT02982187) | GlaxoSmithKline | 2016-12-30 |
| Vahelva Respimat Regulatory Post-marketing Surveillance in Korean Patients With Chronic Obstructive Pulmonary Disease (NCT02864407) | Boehringer Ingelheim | 2016-12-19 |
| Effect of Traditional Chinese Medicine on Outcomes in COPD Patients (NCT03007914) | Henan University of Traditional Chinese Medicine | 2016-12-01 |
| Registry of COPD Patients From Outpatient Polyclinic Healthcare Institutions of the Russian Federation in Moscow (NCT02853383) | Interregional Public Organization, Russian Respiratory Society | 2016-12-01 |
| Hepatitis C Virus(HCV) Heart and Lung Study (NCT02858180) | Duke University | 2016-12-01 |
| Study to Assess the Effect of the Aerobika Device in Addition to Standard of Care Treatment in Sputum Producing COPD Patients Using FRI (NCT02936817) | FLUIDDA nv | 2016-12-01 |
| Respiration Rate Monitoring in COPD Patients (NCT03030313) | ResMed | 2016-12-01 |
| Morphine for Treatment of Dyspnea in Patients With COPD (NCT02429050) | Maastricht University Medical Center | 2016-11-16 |
| Chronic Obstructive Pulmonary Disease Patient Preferences Survey (NCT02970422) | McGill University | 2016-11-01 |
| Effects of Dynamic Hyperinflation on the Left-ventricular Diastolic Function in Healthy Male Subjects (NCT03500822) | Otto Wagner Hospital | 2016-11-01 |
| EVALUATION OF RESPIRATORY MECHANICS AND FUNCTIONALITY IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (NCT03086590) | Universidade Federal de Pernambuco | 2016-11-01 |
| Bronchial Infection in Patients With COPD and Frequent Exacerbations. (NCT03259022) | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | 2016-11-01 |
| Study to Evaluate Safety, Tolerability and Pharmacokinetics of GSK2269557 to Japanese Healthy Subjects (NCT02972905) | GlaxoSmithKline | 2016-10-01 |
| Comparison of Walking in Water and on Land in People With Chronic Obstructive Pulmonary Disease (COPD) (NCT02757157) | European Respiratory Society | 2016-10-01 |
| Influenza Vaccination and COPD Phenotypes (NCT02900209) | University of Lincoln | 2016-10-01 |
| Evaluation of COPD Co-Pilot (NCT02944591) | HGE Health Care Solutions, LLC | 2016-10-01 |
| Evaluate the Efficacy of Xuebijing Injection in Acute Exacerbations of COPD (NCT02937974) | Chinese PLA General Hospital | 2016-10-01 |
| Effect of Tiotropium + Olodaterol on Breathlessness in COPD Patients (NCT02853123) | Boehringer Ingelheim | 2016-09-22 |
| Advancing Symptom Alleviation With Palliative Treatment (NCT02713347) | VA Office of Research and Development | 2016-09-01 |
| A Phase I Pharmacokinetic Study of Fluticasone Furoate /Umeclidinium Bromide/Vilanterol (100/62.5/25 Microgram [mcg]) After Single and Repeat Dose Administration From a Dry Powder Inhaler in Healthy Chinese Subjects (NCT02837380) | GlaxoSmithKline | 2016-09-01 |
| Impact of a Mobile Phone and Educational Intervention (NCT06878898) | Kent State University | 2016-09-01 |
| Magnesium Sulfate to Prevent Hospitalisation of Acute Exacerbations of Chronic Obstructive Pulmonary Disease (NCT02498496) | Hôpital de Verdun | 2016-09-01 |
| Assessment of Physical Functioning and Handling of Spiolto Respimat in Patients With COPD (OTIVACTO) (NCT02720757) | Boehringer Ingelheim | 2016-08-26 |
| Long-term Use of Spiolto Respimat in Japanese Patients With Chronic Obstructive Pulmonary Disease (NCT02850978) | Boehringer Ingelheim | 2016-08-23 |
| SCCOR Minorities Observational Study (NCT02898272) | University of Pittsburgh | 2016-08-01 |